CHAMPIONS ONCOLOGY, INC.

Verified identity

Start with the filing record

The identity and ticker come from the SEC’s official company ticker mapping. Market and editorial coverage are not inferred from that record.

Market price

TickerGrove coverage

Companies

Q1 FY2027 revenue $15.2M (+8.8%) with Non-GAAP oncology services margin at 51%; Adjusted EBITDA $671k while GAAP net loss was $426k.

Published 09-12-2026 · Event 09-10-2026 · Champions Oncology, Inc. Form 8-K — EDGAR index

Research foundation

Company analysis

Revenue is the top-line amount recognized from a company’s activities under its accounting policy.

Company analysis

The income statement records revenue and expenses over a period.

Investing basics

A stock is an ownership interest in one company.